Martini-Klinik - the proof, that Michael Porter's VBHC Model works! - Warsaw, January 31st, 2020 - Center of Value Based Healthcare

Page created by Tracy Hart
 
CONTINUE READING
Martini-Klinik - the proof, that Michael Porter's VBHC Model works! - Warsaw, January 31st, 2020 - Center of Value Based Healthcare
Martini-Klinik -
the proof, that Michael Porter’s VBHC Model works!

Warsaw, January 31st, 2020
                                             Universitätsklinikum Hamburg-Eppendorf
Dr. Detlef Loppow
Martini-Klinik - the proof, that Michael Porter's VBHC Model works! - Warsaw, January 31st, 2020 - Center of Value Based Healthcare
Hospitals offering Radical Prostatectomies 2017

                            410
Martini-Klinik - the proof, that Michael Porter's VBHC Model works! - Warsaw, January 31st, 2020 - Center of Value Based Healthcare
Prostate Cancer Centers 2017
Cases
                                  1 Martini-Klinik

                                                     Johns Hopkins
                                                     Mayo Clinic
                                 2

                                 3-11
        350

                                  115 PCa Centers
Martini-Klinik - the proof, that Michael Porter's VBHC Model works! - Warsaw, January 31st, 2020 - Center of Value Based Healthcare
Open and Robotic Prostatectomies
2800

2600
        open  robotic
2400

2200

2000

1800

1600

1400
                                                    Foundation of
1200
                                                    Martini-Klinik
1000
                                                    2004
800

600

400

200

   0
       1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Martini-Klinik - the proof, that Michael Porter's VBHC Model works! - Warsaw, January 31st, 2020 - Center of Value Based Healthcare
Martini-Klinik - the proof, that Michael Porter's VBHC Model works! - Warsaw, January 31st, 2020 - Center of Value Based Healthcare
The Patient – the Unknown Subject

   Surgery, Recovery, Discharge
            – and then?

 Nearly no clinic knows anything
 about the development of their
    Patients after Therapie!

   Der Tagesspiegel 06.05.2019
Martini-Klinik - the proof, that Michael Porter's VBHC Model works! - Warsaw, January 31st, 2020 - Center of Value Based Healthcare
Martini-Klinik - the proof, that Michael Porter's VBHC Model works! - Warsaw, January 31st, 2020 - Center of Value Based Healthcare
Patient Reported Experience Measures
Would you recommend Martini-Klinik to Friends or Family Members?
Martini-Klinik - the proof, that Michael Porter's VBHC Model works! - Warsaw, January 31st, 2020 - Center of Value Based Healthcare
Integrated Practice Unit

 Founded in 2004 as a
  specialized clinic for
  prostate cancer diagnosis
  and treatment
 Local therapy:
    open/robotic surgery
     RTx
     HDR and LDR-BrachyTx
     AS
     focal therapy
 Chemo-/immunotherapy
  for advanced / metastatic
  disease
Martini-Klinik - the proof, that Michael Porter's VBHC Model works! - Warsaw, January 31st, 2020 - Center of Value Based Healthcare
Diagnostic

 > 8,000 outpatient visits
 > 1,800 prostate biopsies / imaging procedures
          (MRI-fusion / conv. / elastography / HistoScan)
Treatment 2019

 2,646 radical prostatectomies
 100 2nd RG Lymphadenectomies
 > 400 primary radiation therapies
 > 200 active surveillance
 40 focal therapies
Research

 Clinical Studies
  (> 700 Patients included)
 Scientific Output 2016 (2015):
  59 (87) Articles
  323 (560) Impact Points
 > 18 Mio. Euro Industrial
  and Research Funding
  since 2008
Outcome Variation

 2 x variation      in 5 years survival for colorectal cancer between UK primary care trusts
 2 x variation      in 30-day mortality rate from heart attack in US
 4 x variation      in bypass surgery mortality in the UK
 5 x variation      in reoperations due to complications after knee replacement in Germany
 6 x variation      in emergency readmissions after hip surgery in the UK
 9 x variation      in complication rates from radical prostatectomies in the Netherlands
10 x variation      in mortality after rectal cancer surgery in Sweden
18 x variation      in reoperation rates after hip surgery in Germany
20 x variation      in mortality after colon cancer surgery in Sweden
22 x variation      in reoperation rates within 2 years after hip replacements in Sweden
36 x variation      in capsule complications after cataract surgery in Sweden

                 Source: International Consortium for Health Outcome Measurement
Value Based Health Care

          outcomes that matter to patients
Value =
                   cost per patient
Would you judge an airline solely on
  whether you survived the flight?
Would you judge an airline solely on
                                                           whether you survived the flight?

                                                Outcome Quality of Air Travel

 I have survived.                        I arrived in time.                       Staff were very professional / friendly
 The plane live vests on board           The plane was clean.                     Nutrition was of a good quality
 The plane had no technical problems.    Luggage arrived off the plane without    Variety of Entertainment options
                                            any damage or delay.                  
                                                                                 
                                         
                                                                                  
                                                                                   
Then you can only be an average driver...
Healing
Continence
Potency
PROM Martini-Klinik Database

1 Week after Surgery   4 Questions                    Early Continency

6 Months after Surgery Degree 3/4 Clavien Dindo       Complications

Yearly for 10 Years    26 validated Questions         Functional Outcome

                                                      Function of the Bladder
                       EPIC 26                        Function of the Gut
                                                      Erectile Function
                                                      Hormone Therapy

Yearly lifelong        7 Questions                    Oncologic Outcome
Martini-Klinik Database

▪   Clinical and Outcome Data of more than 30.000 Patients
▪   PROM = Patient Reported Outcome Measurement

Outcome Study Group:
2 Data Entry Manager
2 PhD Students
1 Database-Manager
1 Statistician
Shipping of about 2,000
Questionnaires per Month
(QLQC30, IIEF; IPSS, EPIC 26)
Follow-up Data since 1992

                              Basic Quality Control – Benchmarking – Science and Research

             18000                                                                                                                                             85.9
                                                                                                                                                        90.7

             16000    % Patients Sending Follow-Up Information                                                                                   92.5

             14000                                                                                                                        93.5

                                                                                                                                   94.2
             12000      RP per Year
n Patients

                                                                                                                            94.5
             10000
                                                                                                                     94.9
              8000
                                                                                                              94.8
              6000                                                                                     95.2
                                                                                                95.2                 Follow-Up Data
              4000                                                                       95.5
                                                                                  96.6
                                                                           97.5
                                                               97.9 97.6
              2000   97.1 98.2 98.0 98.4 98.0 98.6 98.5 98.0

                 0
Basic Quality Control

▪ Revision < 0.2 %
▪ Colon/Urether Injury < 0.2 %
▪ Blood Transfusion < 5 %
▪ MRSA < 0.1 %
Benchmarking - Every 6 Months!
                                                   pT2 Tumors
               99,4       98,5         98       99,3       100       98,3       100       98,4                     98,2            97,7

    100

    80

    60
%

    40

    20                           7,9                             7,6                  8,8             7,9                      9,1
           4,3        3                     3,5        3                    4,5
     0
           A          B          C          D          E         F          G         H                 I                      J      Surgeo
                                                                                                                                      n
    n     Nerve Sparing Rate
    n     Positive Margin Rate                                                                                           100

                                                                                                 Positive Margin Rates
                                                                                                                          90

                                                                                                 Nerve Sparing and
                                                                                                                          80
                                                                                                                          70
                                                                                                                          60
                                                                                                                          50
                                                                                                                          40
                                                                                                                                               actually
                                                                                                                          30
                                                                                                                          20                   previously
                                                                                                                          10
                                                                                                                           0
Deviation in Quality
                   5

                   4
Number of pads 1

                   3
week post OP

                   2

                   1

                   0
                       A   B   C   D          E   F   G   H
                                    surgeon
Transfer of Innovations
                2,5

                                                                                     non-FFLU, Mean pads/day = 1.49
                                                                                                                       P < 0.0001
                                                                                     FFLU,     Mean pads/day = 0.87
                 2
Pads/d (mean)

                1,5

                                                                                                                               Surgeon A

                 1
                                                                                                           Surgeon B
                                                                                                                               Surgeon C

                0,5

                 0
                      May 08   Jun 08   Jul 08   Aug 08   Sep 08   Oct 08   Nov 08   Dec 08    Jan 09    Feb 09       Mar 09    Apr 09
Prostatectomy

Radicality:                        Quality of life
 Cure                              Continency
 Avoid additional treatments       Potency
NeuroSAFE
             Neurovascular Structure Adjacent Frozen-Section Examination

negative margins =         positive margins =
     nerve sparing         no nerve sparing
NeuroSAFE
                               Impact on Nerve Preservation

                                                Staging      Nerve       Positive
                                                          Preservation   Surgical
             NeuroSAFE 97 %                                              Margins
              Control 81 %                       pT2        99 / 92      7 / 12
            Nerve
                preservation
                all stages
                                                pT3a        94 / 72      21 / 32

                                                pT3b        88 / 40      47 / 51
Schlomm, Eur Urol 2012
              Nerve Preservation in:

              25.561 Cases in Germany 2012:                  32.8 %

              Barmer GEK Report 2012:                        47.4 %
Outcome

                                                  Martini-Klinik 2013

                                                  n = 2147
                                                        600

                                                  88.2 %
                                                  4.2 %
                                                  7.6 %

                                                 NeuroSAFE Reduces
Quelle *3: BARMER GEK Krankenhaus Bericht 2012   Radiation Therapy
Quelle *4: Martini-Klinik Datenbank
Unique Features

▪   The only European Institution exclusively dedicated to prostate cancer
    diagnosis and treatment
▪   Faculty structure
▪   11 Faculty members perform or train all open and robotic prostatectomies
▪   Martini-Klinik faculty position = life time dedication
▪   High level of specialization

                 Clinical experience accumulates in the Martini-Klinik
Faculty Structure

equally ranked,
 equally paid
What have surgeons and cars in common?
Individual Learning Curve

„High-Volume“ Surgeons

                                    Vickers, JNCI 2007
Institutional Learning Curve

                                                                             Start as
                                                                             Surgeon
                                                                                 1992

                         Continence %
                                                                                 2000
                                                                                 1998
                                                                                 2005
                                                                                 2006
                                                                                 2008

Average in Germany                      56.7
Barmer GEK Report 2012

                                        40

                                               Accumulated case experience
International Consortium of Health Outcomes Measurement
Outcome Measurement

   Improves Consultation Quality
   Improves Treatment Quality
   Preserves Quality of Life
   Reduces Follow Up Costs

   Helps to Differentiate to Competitors
Standard Sets for Outcome Measurement

   www.ichom.org
Every patient needs to know the outcome quality
that can be expected prior to the begin of a treatment!
Martinistraße 52
D-20246 Hamburg

Dr. Detlef Loppow             Theodor Billroth, 1860
CEO
Tel.: +49 (0) 40 7410-51307   „Soon the time will come when our students and colleagues will
d.loppow@uke.de               not be satisfied with general comments about this or that success,
www.uke.de                    instead they will call each doctor a charlatan who is not able to
                              express his achievements in figures.”
www.martini-klinik.de

                                                                           Universitätsklinikum Hamburg-Eppendorf
You can also read